Anti-Snoring Treatment Market Share 2022-27: Global Industry Size, Trends, Growth and Forecast

The latest research study “Anti-Snoring Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, reveals that the global Anti-Snoring Treatment market size has reaches US$1.34 billion in 2021. Looking forward to, IMARC Group expects the market to reach a value of US$2.29 billion by 2027 growing at a CAGR of 9.10% during the period 2022-2027.

Impact of Covid-19:

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Industry definition and application:

Snoring refers to loud breath sounds coming from an individual’s nose or mouth. It occurs when the soft tissues of the throat partially obstruct the airways and produce vibrations. It is medically treated with surgery or continuous positive airway pressure (CPAP), in which a mask is worn over the nose or mouth and connected to a machine to deliver a steady stream of air into the nostrils. It can also be cured by lifestyle changes, such as changing sleeping positions, avoiding alcohol, sedatives, maintaining body weight, and relieving nasal obstruction.

Download a free sample brochure: https://www.imarcgroup.com/anti-snoring-treatment-market/requestsample

Anti-Snoring Treatment Market Trends and Drivers:

The market is primarily driven by various technological advancements in anti-snoring treatment devices. Additionally, the growing awareness of individuals regarding the long-term adverse effects of snoring, such as the risk of developing hypertension, stroke, type 2 diabetes, fatigue, heart attacks, and decreased blood oxygen levels, represents another key contributing factor to the market. growth.

Apart from this, loud and frequent snoring is one of the signs of Obstructive Sleep Apnea (OSA), which can lead to cancer, glaucoma, cognitive and behavioral disorders and road accidents. As a result, individuals are widely embracing anti-snoring treatment solutions. This, coupled with the increasing use of anti-snoring apps, tongue stabilization devices (TSDs), behavioral therapies, dental devices and mandibular advancement devices (MADs), also known as advancement therapy (JAD), for treating snoring, is positively influencing the growth of the market.

Other factors including increasing tobacco and alcohol consumption among individuals and growing prevalence of sleep disorders are also creating favorable market prospects across the globe.

Click here to view detailed information with table of contents: https://www.imarcgroup.com/anti-snoring-treatment-market

Scope of the Anti-Snoring Treatment Market Report

Report cover

Details

Market size value in 2021

US$1.34 billion

Market forecast in 2027

US$2.29 billion

Rate of growth

CAGR of 9.10% from 2022 to 2027

Base year for the estimate

2021

Historical data

2016-2021

Forecast period

2022-2027

Report cover

Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

Segments Covered

Device type and distribution channel.

Regional scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Profiled Key Companies

Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips NV, MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH .

Market dynamics

Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period,

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Report segmentation:

The report has segmented the market into the following categories:

Breakdown by device type:

Mandibular Advancement Devices (MADs)

Tongue Stabilizer Devices (TSD)

Continuous Positive Airway Pressure (CPAP) Devices

Others

Breakdown by distribution channel:

Hospital pharmacies

Retail pharmacies

On line

Others

By geography:

North America

oh United States

oh Canada

Asia Pacific

oh China

oh Japan

oh India

oh South Korea

oh Australia

oh Indonesia

oh Others

Europe

oh Germany

oh France

oh UK

oh Italy

oh Spain

oh Russia

oh Others

Latin America

oh Brazil

oh Mexico

oh Others

Middle East and Africa

List of major key players:

Major market players include Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips NV, MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, La company Pure Sleep and Tomed GmbH.

About Us:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Contact us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, Wyoming 82801 USA – Wyoming

E-mail: [email protected]

Such. :(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800